Predictive role of lactate dehydrogenase-to-albumin ratio (LAR) in nonalcoholic fatty liver disease and advanced liver fibrosis. [PDF]
Li G, He T, Geng M, Hong S, Qi F.
europepmc +1 more source
Response to the Comment on "Development and Validation of a Machine Learning-Based Marker for Early Detection and Prognosis Stratification of Nonalcoholic Fatty Liver Disease". [PDF]
Xiao L, Zeng L, Wang J, Hong C, Liu L.
europepmc +1 more source
Influence of an internet-based proactive follow-up management model on the prognosis of nonalcoholic fatty liver disease. [PDF]
Liu SY, Gao GF, Wang XY, Yu J.
europepmc +1 more source
Serum biomarker screening and metabolic profiling analysis of nonalcoholic fatty liver disease patients using untargeted metabolomics and machine learning techniques. [PDF]
Dan L +11 more
europepmc +1 more source
Global, regional, and national burden of nonalcoholic fatty liver disease among adults aged ≥ 45 years: A comprehensive analysis of epidemiological trends and projections to 2035. [PDF]
Wang Q +7 more
europepmc +1 more source
Mediating effect analysis of postprandial triglyceride on Omega-3 and nonalcoholic fatty liver disease in individuals with normal fasting lipid levels. [PDF]
Li L +6 more
europepmc +1 more source
The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease in non-obese individuals: A cross-sectional study. [PDF]
Zhu S, Ding W, Rui X, Yao Y, Yao L.
europepmc +1 more source
Beyond Glucose Control: A Comprehensive Review of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Heart Failure, Chronic Kidney Disease, and Nonalcoholic Fatty Liver Disease. [PDF]
Sosa AR, Sosa MC.
europepmc +1 more source
RETRACTION: Dietary Valine Ameliorated Gut Health and Accelerated the Development of Nonalcoholic Fatty Liver Disease of Laying Hens. [PDF]
Cellular Longevity OMA.
europepmc +1 more source
A critical review of natural products driven correction of bile acid dysregulation: a therapeutic strategy for nonalcoholic fatty liver disease. [PDF]
Peng Q, Hao L, Li S, Yu F, Li N, Hu X.
europepmc +1 more source

